NeuroSense Therapeutics Ltd. Employee Benefits and Share-based Compensation
NeuroSense Therapeutics Ltd. (NRSN) reported Employee Benefits and Share-based Compensation of $878.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Notes › Compensation Related Costs
us-gaap:EmployeeBenefitsAndShareBasedCompensation · last filed 2026-03-31
| Period end | Employee Benefits and Share-based Compensation 12 month | Employee Benefits and Share-based Compensation 12 month as first filed |
|---|---|---|
| 2025-12-31 | $878.00K 20-F · filed 2026-03-31 | |
| 2024-12-31 | $364.00K 20-F · filed 2026-03-31 | |
| 2023-12-31 | $962.00K 20-F · filed 2026-03-31 | |
| 2022-12-31 | $1.16M 20-F · filed 2025-04-07 | $5.11M 20-F · filed 2023-03-22 |
| 2021-12-31 | $4.16M 20-F · filed 2023-03-22 | |
| 2020-12-31 | $2.06M 20-F · filed 2023-03-22 |